LECT2: A pleiotropic and promising hepatokine, from bench to bedside
Open Access
- 3 June 2022
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 26 (13) , 3598-3607
Abstract
LECT2 (leucocyte cell‐derived chemotaxin 2) is a 16‐kDa protein mainly produced by hepatocytes. It was first isolated in PHA‐activated human T‐cell leukaemia SKW‐3 cells and originally identified as a novel neutrophil chemotactic factor. However, many lines of studies suggested that LECT2 was a pleiotropic protein, it not only functioned as a cytokine to exhibit chemotactic property, but also played multifunctional roles in some physiological conditions and pathological abnormalities, involving liver regeneration, neuronal development, HSC(haematopoietic stem cells) homeostasis, liver injury, liver fibrosis, hepatocellular carcinoma, metabolic disorders, inflammatory arthritides, systemic sepsis and systemic amyloidosis. Among the above studies, it was discovered that LECT2 could be a promising molecular biomarker and therapeutic target. This review summarizes LECT2‐related receptors and pathways, basic and clinical researches, primarily in mice and human, for a better comprehension and management of these diseases in the future.Keywords
Funding Information
- National Natural Science Foundation of China (92068206)
This publication has 65 references indexed in Scilit:
- Renal AmyloidosisClinical Journal of the American Society of Nephrology, 2013
- The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic targetCancer Gene Therapy, 2011
- HCC and angiogenesis: possible targets and future directionsNature Reviews Clinical Oncology, 2011
- Leukocyte Chemotactic Factor 2 (LECT2)-Associated Renal Amyloidosis: A Case SeriesAmerican Journal of Kidney Diseases, 2010
- Possible role of LECT2 as an intrinsic regulatory factor in SEA-induced toxicity in d-galactosamine-sensitized miceClinical Immunology, 2010
- Regulation of katanin-P60 levels by LECT2 adjusts microtubular morphologyNeuroReport, 2010
- Suppressive role of leukocyte cell–derived chemotaxin 2 in mouse anti–type II collagen antibody–induced arthritisArthritis & Rheumatism, 2008
- Interferon-γ: an overview of signals, mechanisms and functionsJournal of Leukocyte Biology, 2003
- Systemic expression of a newly recognized protein, LECT2, in the human bodyPathology International, 1998
- Molecular Cloning, Structural Characterization, and Chromosomal Mapping of the Human LECT2 GeneGenomics, 1998